BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
3.340
+0.083 (2.55%)
Dec 5, 2025, 2:38 PM EST - Market open
BioLineRx Market Cap
BioLineRx has a market cap or net worth of $13.69 million as of December 5, 2025. Its market cap has decreased by -64.35% in one year.
Market Cap
13.69M
Enterprise Value
-438.62K
1-Year Change
-64.35%
Ranking
Category
Stock Price
$3.34
Market Cap Chart
Since July 27, 2009, BioLineRx's market cap has decreased from $33.80M to $13.69M, a decrease of -59.49%. That is a compound annual growth rate of -5.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 13.69M | -41.71% |
| Dec 31, 2024 | 23.49M | -79.62% |
| Dec 31, 2023 | 115.26M | 305.33% |
| Dec 29, 2022 | 28.44M | -71.41% |
| Dec 30, 2021 | 99.46M | 66.19% |
| Dec 31, 2020 | 59.85M | 124.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |